European court rules against stem cell patents in research

In a decision that will have far-reaching consequences for regenerative medicine, the European Court of Justice has ruled that inventions requiring the destruction of human embryos, or their prior use as base material, cannot be patented under European law if the purpose is purely for scientific research.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Luxembourg